Axxess Pharma Inc. - ( AXXE )
The last time we Alerted AXXE the stock had Just Gapped on Monstrous Volume of $170K. The company was Scorching with Corporate Developments, and the stock ended up rewarding our call with a 20SMA Break and Moderate run to $.225. Given all the Perfect Ingredients for a Run, the stock pulled back before BLASTING OFF to ~$.32 last week!! For those that Held, You are Welcome!!! AXXE DOLLAR VOLUME has gone WILD in 2014 making this Volatile and Liquid Equity a Great Trade once again on this most Recent Pullback to the Current Price of $.22!
AXXE traded ~$750,000 in One Day alone last week.
The TA shows a Golden Cross, Rising Support Levels from the 20SMA, a Bullish RSI after being moderately overbought, and Tantalizing 200SMA ($.56) and Research Report ($.89) Targets coming into View!
A ~43.4MIL OS may cause these Targets to be Hit Sooner than one would think! The Company had been reporting Significant Growth Events per our Last Alert, and the Momentum has Only Become Stronger!
AXXE has had 6 Major Releases since the Intial Alert.
Today AXXE Blitzed Shareholders with a New TapouT Order From Victory after a SELL-OUT of these Products! Clearly the Demand is THERE, and AXXE intends to increase their supply to meet it! Global Expansion, Product Demand, and New Marketing Personnel have all been Acheieved in the Latest String of AXXE Developments that have pushed Dollar Volume and Trader Interest to NEW HIGHS! The company has given us the following developments to match the impressive growth detailed in the last alert:
- AXXE signed on Champion Bodybuilder Michael Spencer as a TapouT Spokesperson.
- They Launched their New TapouT Product 'TapouT Extreme Muscle'!
- As previously noted, AXXE SOLD OUT the Initial Order of TapouT Pain Relief Products With Victory Brands Inc., a Leading Canadian Distributor!
- AXXE Announced the Expansion of the TapouT Product Line Into Latin America With an Affiliate Office in Mexico City.
- AXXE Detailed New Orders via TapouT Sales in Canada With Victory Brands Inc., a Leading Canadian Distributor.
- AXXE Furthered California Market Penetration through their Wholly-Owned Subsidiary AllStar Health Brands. They Received their First Purchase Order for TapouT Pain Relief and Muscle Recovery Products.
Axxess Pharma Inc. (AXXE) is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, -- to optimal health management through improved nutritional supplements.
The PRODUCTS PAGE Detailing Prescription, Non-Prescription, and Launch Dates are essential reads. These are the Key to Growing Revenues and Valuation Catalysts that may take AXXE Stock higher.
Visit http://www.axxesspharmainc.com/ for more Corporate, Product, and News Information.
AXXE has was given a $.89 PRICE TARGET by Murphy Analytics - A Potential 305% ROI if you Buy at Current Market Prices!! The Investment Thesis has only gained Strength since the Initial Report given that AXXE has grown their Partnerships, Sales Demands, Brand Name, and Goals! Let's Look at the Newest Releases that have yet to be considered in the Price Target!
Today AXXE Kept the Wires HOT HOT HOT! AXXE Announced a New TapouT Product Order from Victory Brands Following the Sell-Out of Initial Order!
- The new order was placed through Axxess Pharma's wholly-owned subsidiary; AllStar Health Brands Inc. Victory Brands is Canada's leading distributors of Health, Fitness and Nutrition products.
- Based on the success of the initial sales effort, AllStar and Victory are preparing a more comprehensive marketing campaign aimed at expansion into larger retail outlets.
- Daniel Bagi, President of Axxess stated, "We are extremely delighted with this new order. We are working hard to drive further growth and reach more customers through a ramp-up in marketing of our TapouT line."
- Based on the success of this initial sales effort, Axxess and Victory are preparing a more comprehensive marketing campaign aimed at expansion into larger retail outlets.
- Daniel Bagi, President of Axxess further stated, "We believe the initial sell out of our TapOut pain relief products bodes well for our growth across Canada. We are now we formulating a specific marketing strategy together with the team at Victory to ensure success, and expand into all major retailers in Canada."
- Michael was formerly a spokesperson for globally branded Muscle Pharm.
- His list of Impressive Achievements is fully detailed in the Release.
- Dr. Bagi, President of Axxess Pharma stated: "Michael Spencer embodies the spirit of our company, with his strong family focus and work ethic. We are thrilled to have him on board. We believe our products provide natural and effective options to athletes and everyone who wants to live a healthy and active lifestyle."
- A new product is set to be launched through on-line and retail channels. TapouT Extreme Muscle, a product under development for the past six months, is a powerful new supplement that combines the best natural ingredients for today's active men.
- TapouT Extreme Muscle naturally boosts testosterone levels which builds muscle, burns fat and enhances the libido. The formula is supported with fat-burning, energizing ingredients and powerful nitric oxide pre-cursors.
- Dr. Bagi, President of Axxess Pharma stated: "This exciting new product is in line with our strategy of offering new products which can optimize Quality of Life through targeted natural ingredients. We expect to be in production within the next two weeks, and have the product available online and in retail stores by February."
AXXE is Pushing Forward Aggressively in a Global Market where Demand is Booming! 2013 has been Flush with International Expansion, and AXXE hit another Home Run! In Late November, AXXE Announced Expansion of its TapouT Product Line Into Latin America With an Affiliate Office in Mexico City! Brazil and Mexico are Expected to Be Large Growth Markets for TapouT Product Line and Cancer Drugs!!
- AXXE will establish a Latin American division headquartered in Mexico City, Mexico to handle the Sales & Marketing efforts for the region.
- Latin America is widely known for their strong interest in the UFC and the TapouT product line. Axxess Pharma anticipates strong revenue within region!
- The tremendous popularity of the UFC and TapouT in Latin America, especially in Brazil and Mexico necessitates an AXXE presence on the ground to manage both their TapouT and pharmaceutical lines. The company has already begun the process of establishing Axxess Pharma as a corporate entity in Mexico, and expects to begin operations in the New Year, with sales in the region beginning shortly after! LOOK FOR FINANCIAL GROWTH!!!!
- How Special is the Latin America Industry and Demand for these Products and Services? Very Special!
- Dr. Bagi, M.D. stated, "Latin America as a region has a population of over 500 million and is one of the fastest growing markets in the world. With the popularity and growth of the UFC and the TapouT brand, we felt the timing was right for this expansion. We are also very close to submitting pharmaceutical cancer drug dossiers for approval in Mexico. In August of 2013, our Company acquired the Mexican and Latin American rights to the cancer drugs from a leading Canadian manufacturer."
AXXE has been Hitting the Canadian Markets Hard, and Shareholders Love it! The company is Exploding to the North and South of the USA with Authority. Shortly after our November Alert, AXXE Announced More TapouT Sales in Canada With Victory Brands Inc., a Leading Canadian Distributor Canada-Wide Distribution of TapouT Pain Relief and Muscle Recovery Products Commences.
- AllStar Health Brands Inc. has signed with Victory Brands, one of Canada's leading distributors of Health, Fitness and Nutrition products to sell its TapouT branded products into mass retail, specialty, pharmacies and select online retailers.
- Initial orders have been placed and Axxess expected to be in several of the mass retailers and online later that month.
We must be cognizant of the Developments AXXE Achieved and Continues to Expand upon in the September-November Timeframe:
- On November 18th, AXXE's Wholly-Owned Subsidiary AllStar Health Brands Received its First Purchase Order for TapouT Pain Relief and Muscle Recovery Products. Shareholders should expect Rapid Sales Increases over the Coming Months!!!
- AllStar Health Brands Inc., has received their first purchase order of TapouT pain relief and muscle recovery products from California-based Delivery Agent, Inc. (http://www.deliveryagent.com/).
- Axxess Pharma Inc. anticipates strong, residual purchase orders from Delivery Agent, Inc. in the coming months.
- In addition to Delivery Agent, Inc.'s recent order, Axxess Pharma's wholly owned subsidiary AllStar Health Brands' TapouT products will now be available to customers around the world through a number of websites including http://www.tapout.com/, http://www.supplementsource.ca/ and http://www.vitamart.ca/. Millions of customers from around the world visit TapouT.com each month.
- In Early November, AXXE Secured an Online-Sales Strategic Partnership for their TapouT Product Line With Vortex Traffic - a Global Leader in Digital Marketing.
- Since 2007 Vortex has produced over $140 million in global sales for its clients, primarily in the health and beauty industry.
- On October 30th, AXXE Received a $4 Million Revolving Line of Credit to Fund Worldwide Product Expansion and Generate Significant Revenue in the Near-Term.
- The Company Signed an Exclusive World-Wide License to Market and Sell TapouT Brand Vitamins & Minerals Pain Relief and Muscle Recovery Products.
- There are six products, ready to launch and we anticipate TapouT and AXXE will mutually benefit tremendously from this alliance. The power of the TapouT brand is immense. This agreement will be a major priority to the Company and is anticipated to generate strong global sales.
- AXXE Formed the New Subsidiary AllStar Health Brands Inc. to Market Natural and Sports Brands Online and in Retail Stores.
- In Mid-September, AXXE Acquired the Existing Revenues, Patents, Formulations and NFL, NHL, UFC Athlete Endorsed Products From a Leading Canadian OTC Healthcare Company.
Now do you see how these Releases are More Significant than you realize? The Results are About to Hit, and we think the Stock Price May get Lit Up!!!!! Murphy Analytics is VERY BULLISH on AXXE given the Progress the company continues to make in rapid fashion. The expectations and results coming in are the stuff of legend for a $.22 stock!!!
What is their Outlook for AXXE? Here is the AXXE RESEARCH REPORT. An Update would More than Likely Yield Even Greater Estimates Given the Recent Successes and Expansion.
- As noted in the Company’s business plan, available via its website, AXXE is projecting some near term revenue, increasing to $6.2 million in revenue next year, then $13 million and $20.4 million by 2016.
- As illustrated later in this report, if the Company is successful in hitting its net income targets, Murphy Analytics
(MA) expects a price as high as $0.89 may be justifiable currently based on AXXE’s projected operating results.
- As is the case with every stock, the potential price range for AXXE is a theoretically unlimited upside, and a downside of $0.00; and the Company faces a number of significant operational, financial, and competitive challenges and risks. However, with a recently announced line of credit term sheet, AXXE is demonstrating further progress in developing a model to capitalize on highly attractive market opportunities. If the Company is able to continue making progress in executing its business plan and operating goals over the coming quarters, AXXE has an opportunity to demonstrate to the market that a discounted stock price based on expected future years’ projections is justifiable.
AXXE pulled off Several Developments previous to the aforementioned releases, and they are Must-Read Material as well. There is SO MUCH that AXXE has done in 2013, and we are shocked that the price is so low right now!!! Marketing/Licensing rights in Huge Markets such as Canada and Mexico, Additions of Industry Professionals, an Acquisition, and Partnerships are all part of the AXXE story that has been coming into a most Bullish view.
Recall the PHARMACEUTIVAL VENUES that AXXE is Inolved in! There is So Much Happening with this company that Investors Lose Sight of the Initial Value, Acquisitions, Patents, Strategies, etc. that the company has created. This company is growing sales via the Cancer, Pain, Baby Care, and Vitamin markets in aggressive style!
The action all began in early June when this pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, announced they were current in their filings on OTCMarkets.com. Clearly, Liquidity and Trading Action has Improved due to these Moves.
AXXE has Initiated the Next Step Towards Bulletin Board (OTCBB) Listing. The NASDAQ Listing is Anticipated in the Second Quarter 2015. Liquidity should increase through these listings. Over the last 15 months, AXXE has worked diligently to bolster management, and initiate revenues and profits through prescription drugs and over-the-counter nutritional supplements.
The Listing opened the PR floodgates regarding product licensing, product distribution, revenues, and brand marketing. The action is expected to continue!!!
With a price of $.22 and OS of ~43MIL, AXXE stands to make traders some Big Gains as volatility ramps up. The Developments are concrete. AXXE is in its best situation yet to grow sales and build its brand names across North America and Globally. Let's look closely at these corporate moves that are augmenting value for shareholders in a dazzling fashion.
- In early September, AXXE Signed an Agreement with a Top Mexican Pharmaceutical Company - Industria Farmaceutica Andromaco, S.A. de C.V.
- Under the agreement, Axxess Pharma's product, Soropon, will be marketed in Mexico by Andromaco. Axxess has also secured the rights to market in Canada, several of Andromaco's market leading baby-care products.
Mexico is a Huge Opportunity for AXXE Growth. The success of Andromaco showcases just how valuable the AXXE Product Line and Presence here may be.
Dr. Daniel Bagi, President of AXXE, stated:
With a population three times that of Canada's and a higher birth rate than Canada's, AXXE is extremely pleased with the market possibilities in Mexico for Soropon and we anticipate robust sales for Soropon in Mexico, starting in 2014. Two of Andromaco's baby care products are among the market leaders in Mexico with annual sales in excess of ten million dollars (US). Andromaco also generates sales exporting and selling into the US. These products are manufactured in Andromaco's US FDA-approved facility. Their product offerings in infant skin care will add to our OTC infant skincare product line for the Canadian market."
AXXE is Growing through Acquisitions. They have a strategic growth model based on certain products, target markets (Age, Medicine, Nation), branding, etc.
- September 2nd was a big day for AXXE as they released a MOU to Acquire a Leading Canadian OTC Healthcare Company.
- Upon completion of the acquisition, the company will bring current sales and a valuable IP portfolio to AXXE.
The Canadian Corporation, based in Toronto, has an attractive IP portfolio including a best-selling, patented, OTC pain relief formula. The company also has a number of unique formulas and world class brand products that Axxess Pharma will be able to immediately leverage, with existing distribution.
They will bring a number of experienced executives to AXXE to assist in growing sales across North America, and online. Per the President of AXXE, "This acquisition will facilitate access to capital and generate a rapid ramp-up of sales. We anticipate major revenue growth in the near term with this acquisition."
This plan was revealed and set in motion via a July 16th release stating the companies were having discussions over the agreement. Through exclusive license with this brand, AXXE felt they will be able to penetrate mass retail across North America including the major box stores very quickly as the brand is widely recognized as a global leader. AXXE has planned for this to result in nearly immediate revenues for the company.
This company is PUSHING THE GROWTH ENVELOPE! Traders are LOVING the CONSTANT BARRAGE of NEWS that Offers Tanglibe Growth in Multiple International Markets and Product Venues! Historical success is a key component of selecting the RIGHT Stocks to Trade and Invest with in the Small-Cap universe. If we look at the DAILY CHART, you will notice that AXXE has seen its fair share of WAVES to Trade. AXXE has NEVER LOOKED HOTTER!!!!
- AXXE is in the Midst of Pull-Back after Running to ~$.32 on HUGE VOLUME - Several Hundred Thousand Dollars are being traded here!
- Targets are the Recent High (~$.32), the 200SMA ($.56), and the Murphy Analytics Target ($.89). Potential Returns on Runs to these Targets are 45%-154%-305%!!!
- MACD Remains Positive, a GOLDEN CROSS Hit Last Week, and RSI is Bullish at ~54!
- This stock offers substantial liquditiy, and the developments will only heat up with New Products, International Demand, Effective Branding, and SALES now coming into view!
As Revenues Grow on the backs of Product releases, Branding, and International Market Penetration in 2013 and early 2014, this ~43.4MIL OS may be devoured in amazing fashion. Small-Cap trades offer some of the most incredible Returns in Any industry - multi-baggers come around often in this landscape. AXXE is trying to position itself as the next all-star trade. They have gained valuable assets through licensing rights, product rights, team personnel, and more in capitalizing upon leading Health and Wellness, Cancer, Baby Care, Vitamin, and Pain management markets.
We hope you enjoy AXXE, and we look forward to following them as they implement their business strategies.
Trade wisely, and continue to do your research!
Stockcaht LLC has received Eight Thousand Dlrs for the awareness of AXXE by a non-controlling third party Romas & Romas LLC. Stockchat LLC has previously been compensated a total of Seven Thousand Five Hundred Dlrs for the awareness of AXXE by a non-controlling third party Romas & Romas, which has since expired.